---
id: 129
title: Treponema pallidum (Syphilis) Diagnosis and Staging
category: organisms
subcategory: spirochetes
tags: [syphilis, treponema, RPR, VDRL, FTA-ABS, TP-PA, neurosyphilis]
difficulty: medium
---

## Question

How is syphilis diagnosed and staged? Use the **"Nontreponemal (RPR/VDRL) + Treponemal (FTA-ABS/TP-PA)"** framework with **"Penicillin for All Stages"**.

## Answer

### **Syphilis Staging:**

| Stage | Timeline | Clinical Features | Treatment |
|-------|----------|------------------|-----------|
| **Primary** | **3 weeks** (range 10-90 days) post-exposure | **Painless chancre** (single, indurated ulcer) + regional lymphadenopathy; **heals in 3-6 weeks** | **Benzathine PCN G 2.4 MU IM × 1** |
| **Secondary** | **6-12 weeks** post-exposure (or weeks-months after chancre) | **Rash** (palms/soles, maculopapular), **condyloma lata**, **mucous patches**, lymphadenopathy, fever, alopecia | **Benzathine PCN G 2.4 MU IM × 1** |
| **Early Latent** | **<1 year** from infection | **Asymptomatic**, positive serology | **Benzathine PCN G 2.4 MU IM × 1** |
| **Late Latent** | **>1 year** from infection (or unknown duration) | **Asymptomatic**, positive serology | **Benzathine PCN G 2.4 MU IM weekly × 3 doses** |
| **Tertiary** | **Years to decades** | **Gummas** (granulomas), **cardiovascular** (aortitis, aortic aneurysm), **neurosyphilis** | **Benzathine PCN G 2.4 MU IM weekly × 3** OR **neurosyphilis regimen** |

### **Diagnostic Testing:**

**Traditional Algorithm:**

1. **Nontreponemal test** (screening):
   - **RPR (Rapid Plasma Reagin)** OR **VDRL (Venereal Disease Research Laboratory)**
   - **Quantitative titer** (e.g., 1:4, 1:16, 1:128)
   - **Used for:** Screening, monitoring treatment response

2. **If nontreponemal positive → Treponemal test** (confirmatory):
   - **TP-PA (T. pallidum Particle Agglutination)** OR **FTA-ABS (Fluorescent Treponemal Antibody Absorption)**
   - **Remains positive lifelong** (cannot use for treatment monitoring)

**Reverse Algorithm (many labs now use):**

1. **Treponemal test** (screening): Automated EIA/CIA
2. **If treponemal positive → Nontreponemal test** (RPR/VDRL)

**Interpretation:**

| RPR/VDRL | Treponemal (TP-PA/FTA-ABS) | Interpretation |
|----------|---------------------------|----------------|
| **+** | **+** | **Active or past infection** (use titer to guide) |
| **-** | **+** | **Treated syphilis** OR **late latent** OR **false positive treponemal** |
| **+** | **-** | **False positive nontreponemal** (pregnancy, autoimmune, viral infections) |
| **-** | **-** | **No infection** (or very early primary) |

### **Neurosyphilis:**

**Indications for LP:**
- **Neurologic symptoms** (vision changes, hearing loss, cranial nerve palsies, meningismus, stroke)
- **Ocular syphilis** OR **otic syphilis**
- **Tertiary syphilis** (cardiovascular, gummatous)
- **Treatment failure** (RPR titer fails to decline 4-fold by 6-12 months)
- **HIV with late latent/tertiary** (controversial, some experts recommend)

**CSF Findings:**
- **CSF-VDRL:** **Specific** (near 100%) but **low sensitivity** (30-70%)
- **CSF-FTA-ABS:** **Sensitive** but **NOT specific** (can be false positive from blood contamination)
- **CSF:** Lymphocytic pleocytosis (>5 WBC/μL), elevated protein

**Treatment:**
- **Penicillin G 18-24 million units/day IV** (continuous infusion or divided q4h) × **10-14 days**
- **Alternative:** **Ceftriaxone 2g IV daily × 10-14 days** (less data, not FDA-approved)

## Key Points

### **Monitoring Treatment Response:**

**Nontreponemal titer (RPR/VDRL):**
- **Should decline 4-fold (2 dilutions) by 6-12 months** (e.g., 1:128 → 1:32)
- **Serologic cure:** Titer becomes nonreactive (not always achieved in late syphilis)
- **Persistent low titers (serofast):** Common in late latent/tertiary (not treatment failure if asymptomatic)

**Treatment Failure:**
- **RPR titer fails to decline 4-fold by 6-12 months** OR **increases 4-fold**
- **Re-evaluate:** Consider neurosyphilis (LP), HIV testing, re-treatment

### **Jarisch-Herxheimer Reaction:**
- **Acute febrile reaction** (fever, chills, myalgia, headache) **within 24 hours** of treatment
- **Common** in early syphilis (especially secondary)
- **Self-limited** (resolves in 12-24 hours)
- **Management:** Supportive (antipyretics), **NOT an allergy** (can continue penicillin)

### **Congenital Syphilis:**
- **Screen all pregnant women** at first visit (+ 3rd trimester if high-risk)
- **Treatment in pregnancy:** Benzathine PCN G (same regimen as non-pregnant)
- **Penicillin desensitization** if penicillin-allergic (no alternatives in pregnancy)
- **Neonatal manifestations:** Hepatosplenomegaly, rash, osteochondritis, snuffles, pseudoparalysis

### **Clinical Pearls:**
- **Primary:** Painless chancre → benzathine PCN G 2.4 MU IM × 1
- **Secondary:** Rash (palms/soles), condyloma lata → benzathine PCN G 2.4 MU × 1
- **Late latent/tertiary:** Benzathine PCN G 2.4 MU IM weekly × 3
- **Neurosyphilis:** Penicillin G 18-24 MU IV daily × 10-14 days
- **Monitor RPR/VDRL titers** (should decline 4-fold by 6-12 months)
- **Jarisch-Herxheimer:** Fever within 24h (NOT allergy, self-limited)
- **Treponemal tests remain positive lifelong** (cannot use for monitoring)

## Sources

- [CDC: Syphilis Treatment Guidelines 2024]
- [IDSA: Syphilis Guidelines 2023]

## Media

N/A
